Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Shi

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Nature|June 1, 2022
Combination anti-HIV antibodies provide sustained virological suppressionMichael C Sneller, Jana Blazkova, J Shawn Justement, et al.
Radiology|August 5, 2025
MRI-based Ovarian Lesion Classification via a Foundation Segmentation Model and Multimodal Analysis: A Multicenter StudyWen-Chi Hsu, Yuli Wang, Yu-Fu Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 LevelsJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Archives of Dermatological Research|January 20, 2024
Clinical relevance and uptake of core outcome sets in dermatologyAreeba Ahmed, Eric Koza, Victoria Shi, et al.
Archives of Dermatological Research|March 18, 2024
Methodological innovations and stakeholder involvement in core outcome sets for skin diseases: a survey of the C3 working groupsAreeba Ahmed, Eric Koza, Victoria Shi, et al.
Science Translational Medicine|December 8, 2017
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infectionMichael C Sneller, J Shawn Justement, Kathleen R Gittens, et al.
Nature Medicine|January 3, 2025
Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavirM Ali Rai, Jana Blazkova, Lela Kardava, et al.
Journal of Clinical Epidemiology|May 23, 2026
What US Medical Students Need to Learn About Clinical Practice Guidelines: A Qualitative Study of US Students and a Global Subset of Guidelines DevelopersMichael D Yi, Victoria Shi, Rachel E Christensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
Annals of Internal Medicine|May 23, 2022
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline FindingsMichael C Sneller, C Jason Liang, Adriana R Marques, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Nature|June 1, 2022
Combination anti-HIV antibodies provide sustained virological suppressionMichael C Sneller, Jana Blazkova, J Shawn Justement, et al.
Radiology|August 5, 2025
MRI-based Ovarian Lesion Classification via a Foundation Segmentation Model and Multimodal Analysis: A Multicenter StudyWen-Chi Hsu, Yuli Wang, Yu-Fu Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 LevelsJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Archives of Dermatological Research|January 20, 2024
Clinical relevance and uptake of core outcome sets in dermatologyAreeba Ahmed, Eric Koza, Victoria Shi, et al.
Archives of Dermatological Research|March 18, 2024
Methodological innovations and stakeholder involvement in core outcome sets for skin diseases: a survey of the C3 working groupsAreeba Ahmed, Eric Koza, Victoria Shi, et al.
Science Translational Medicine|December 8, 2017
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infectionMichael C Sneller, J Shawn Justement, Kathleen R Gittens, et al.
Nature Medicine|January 3, 2025
Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavirM Ali Rai, Jana Blazkova, Lela Kardava, et al.
Journal of Clinical Epidemiology|May 23, 2026
What US Medical Students Need to Learn About Clinical Practice Guidelines: A Qualitative Study of US Students and a Global Subset of Guidelines DevelopersMichael D Yi, Victoria Shi, Rachel E Christensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
Annals of Internal Medicine|May 23, 2022
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline FindingsMichael C Sneller, C Jason Liang, Adriana R Marques, et al.
Pageof 8